WallStreetZenWallStreetZen

NASDAQ: VSTM
Verastem Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for VSTM

Based on 3 analysts offering 12 month price targets for Verastem Inc

Min Forecast
$15.00+170.76%
Avg Forecast
$17.33+212.87%
Max Forecast
$19.00+242.96%

Should I buy or sell VSTM stock?

Based on 3 analysts offering ratings for Verastem Inc.

Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although VSTM's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates VSTM as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their VSTM stock forecasts and price targets.

VSTM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-04-23
lockedlocked$00.00+00.00%2026-04-10
lockedlocked$00.00+00.00%2026-03-30

1 of 1

Forecast return on equity

Is VSTM forecast to generate an efficient return?

Company
-76.75%
Industry
66.25%
Market
172.91%
VSTM's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is VSTM forecast to generate an efficient return on assets?

Company
-17.81%
Industry
30.34%
VSTM is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

VSTM earnings per share forecast

What is VSTM's earnings per share in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
-$1.67
Avg 2 year Forecast
-$0.75
Avg 3 year Forecast
-$0.48

VSTM revenue forecast

What is VSTM's revenue in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
$118.3M+282.64%
Avg 2 year Forecast
$203.8M+559.09%
Avg 3 year Forecast
$297.9M+863.51%
VSTM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

VSTM revenue growth forecast

How is VSTM forecast to perform vs Biotechnology companies and vs the US market?

Company
112.39%
Industry
37.38%
Market
14.35%
VSTM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
VSTM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

VSTM vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VSTM$5.54$17.33+212.87%Strong Buy
DNA$7.82$8.50+8.70%Hold
CTNM$12.97$18.67+43.92%Buy
FDMT$9.45$30.67+224.52%Strong Buy
ENGN$7.20$21.08+192.82%Buy
View Top Biotech Stocks

Verastem Stock Forecast FAQ

Is Verastem Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: VSTM) stock is to Strong Buy VSTM stock.

Out of 3 analysts, 2 (66.67%) are recommending VSTM as a Strong Buy, 1 (33.33%) are recommending VSTM as a Buy, 0 (0%) are recommending VSTM as a Hold, 0 (0%) are recommending VSTM as a Sell, and 0 (0%) are recommending VSTM as a Strong Sell.

If you're new to stock investing, here's how to buy Verastem stock.

What is VSTM's earnings growth forecast for 2026-2028?

(NASDAQ: VSTM) Verastem's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.71%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 35.62%.

Verastem's earnings in 2026 is -$209,471,000.On average, 11 Wall Street analysts forecast VSTM's earnings for 2026 to be -$146,930,565, with the lowest VSTM earnings forecast at -$154,941,127, and the highest VSTM earnings forecast at -$137,418,023. On average, 11 Wall Street analysts forecast VSTM's earnings for 2027 to be -$65,498,639, with the lowest VSTM earnings forecast at -$116,205,845, and the highest VSTM earnings forecast at $117,128,114.

In 2028, VSTM is forecast to generate -$42,239,902 in earnings, with the lowest earnings forecast at -$82,635,268 and the highest earnings forecast at -$5,533,612.

What is VSTM's revenue growth forecast for 2026-2028?

(NASDAQ: VSTM) Verastem's forecast annual revenue growth rate of 112.39% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.38%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.35%.

Verastem's revenue in 2026 is $30,914,000.On average, 11 Wall Street analysts forecast VSTM's revenue for 2026 to be $10,390,014,689, with the lowest VSTM revenue forecast at $8,332,389,496, and the highest VSTM revenue forecast at $12,801,088,348. On average, 11 Wall Street analysts forecast VSTM's revenue for 2027 to be $17,896,402,848, with the lowest VSTM revenue forecast at $14,758,932,861, and the highest VSTM revenue forecast at $24,136,208,778.

In 2028, VSTM is forecast to generate $26,162,564,673 in revenue, with the lowest revenue forecast at $19,428,247,096 and the highest revenue forecast at $33,570,577,513.

What is VSTM's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: VSTM) forecast ROA is -17.81%, which is lower than the forecast US Biotechnology industry average of 30.34%.

What is VSTM's Price Target?

According to 3 Wall Street analysts that have issued a 1 year VSTM price target, the average VSTM price target is $17.33, with the highest VSTM stock price forecast at $19.00 and the lowest VSTM stock price forecast at $15.00.

On average, Wall Street analysts predict that Verastem's share price could reach $17.33 by Apr 23, 2027. The average Verastem stock price prediction forecasts a potential upside of 212.87% from the current VSTM share price of $5.54.

What is VSTM's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: VSTM) Verastem's current Earnings Per Share (EPS) is -$3.02. On average, analysts forecast that VSTM's EPS will be -$1.67 for 2026, with the lowest EPS forecast at -$1.76, and the highest EPS forecast at -$1.56. On average, analysts forecast that VSTM's EPS will be -$0.75 for 2027, with the lowest EPS forecast at -$1.32, and the highest EPS forecast at $1.33. In 2028, VSTM's EPS is forecast to hit -$0.48 (min: -$0.94, max: -$0.06).

What is VSTM's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: VSTM) forecast ROE is -76.75%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.